12.21.16 By Sanofi Le Hub
Sanofi Morocco participated at the recent COP22 in Marrakech as a partner. Through its Moroccan subsidiary, the company confirms its commitment to fight against climate change and its impacts on public health.
After raising awareness of health-related issues at COP21, the international conference on climate change held last year in Paris, Sanofi took part in COP22, which ran from November 8 to 18. As the venue was in Marrakech, Morocco – the first time a COP event has been held in Africa – Sanofi was represented by its Moroccan subsidiary, Sanofi Morocco.
“The World Health Organization (WHO) has forecast that climate change is likely to result in 250,000 additional deaths annually by 2030 through causes such as undernutrition, malaria and diarrhea exacerbated by a variety of factors including a lack of food security, worsening poverty and poor air quality,” explains Ophra Rebière, Sanofi’s Head of Corporate Social Responsibility.
The Company is devoting resources to strategies trying to bring about improvements to public health issues exacerbated by global warming.
Its strategy on malaria is a case in point. Sanofi supplies affordable medicines and helps provide facilities for prevention, diagnosis and treatment. It has formed partnerships with a number of national programs in Africa, and has developed a patent-free anti-malarial medicine, ASAQ Winthrop. Some 450 million doses were distributed in more than thirty sub-Saharan countries between 2007 and 2015.
Sanofi is committed to fighting the effects of global warming. As a responsible corporate citizen, it is taking drastic steps to reduce its own greenhouse gas emissions as sharply as possible. It is aiming for a 20% decrease in CO2 between 2010 and 2020. By 2015, the halfway point, it had cut its emissions by 15%.
One of the vectors for reducing the carbon footprint has been transport. Whenever possible, Sanofi favors maritime shipping over air freight. It makes approximately 86% of its intercontinental shipments are made by sea, compared to an average of 28% for other players in the healthcare sector.
Find out more about Sanofi’s commitment to the fight against climate change in our long read.
3 questions to…
… Aziz Yousfi Malki, Sanofi’s Head of Communications & Corporate Social Responsibility for Morocco, Tunisia and Libya
How was the partnership between Sanofi’s Moroccan company and the COP 22 steering committee formed? What actually is Sanofi’s role in Morocco?
Sanofi Morocco was contacted by the COP 22 Steering Committee.
Sanofi Morocco has worked closely with the Corporate CSR team to build a program of participation content to provide a logical link between the Sanofi Corporate participation in COP 21 and its presence at COP 22.
A partnership has also been formed with the CFCIM (French Chamber of Commerce and Industry in Morocco) to pool attendance and exhibition resources.
How Sanofi Morocco’s communication were organised? Which key issues did the company talk about on this occasion?
The company participated at two conferences on the impact of climate change on health. The Moroccan company also implemented an action strategy for public affairs led by General Manager Morocco Amine Benabderrazik.
Sanofi was honoured by the visit of the official French delegation, chaired by the French President.
Three key issues were addressed by Sanofi on this occasion in response to the health problems exacerbated by climate change: medications and awareness, the carbon footprint and international collaboration.
What initiatives does Sanofi Morocco have in place to prevent the risks posed by climate change to human health? What are its priorities?
Sanofi’s Moroccan subsidiary makes an active contribution to the issues of malaria. Between 2007 and 2015, Sanofi Morocco produced more than 415 million doses of the ASAQ Winthrop® antimalarial, distributed in more than 30 countries of Sub-Saharan Africa.
Moreover, Sanofi Morocco is strongly committed to improve its energy efficiency, which is a key issue in the fight against global warming. The Moroccan subsidiary’s Maphar plant in Zenata, near Casablanca, is currently engaged on a program to achieve ISO 50001 certification for energy management systems.
It has devised a three-year plan that includes a series of innovative techniques as smart energy purchasing, energy recovery, LED lighting, solar power to product hot water and air processing supervisor systems. There will also be employee awareness-raising and training programs on the importance of energy efficiency in the improvement of plant performance.
Recommended by Sanofi Le Hub
05.17.17 By Sanofi Le Hub
03.28.17 By Sanofi Le Hub
12.14.16 By Sanofi Le Hub
08.09.17 | By Sanofi Le Hub
10.28.16 | By Sanofi Le Hub
10.24.16 | By Sanofi Le Hub
10.14.16 | By Sanofi Le Hub
10.07.16 | From WHO
09.29.16 | By Sanofi Le Hub
09.21.16 | By Sanofi Le Hub
09.15.16 | By Sanofi Le Hub
09.09.16 | By Sanofi Le Hub
09.01.16 | By Sanofi Le Hub
08.24.16 | By Sanofi.fr
08.12.16 | By Sanofi Le Hub
08.03.16 | By Sanofi Le Hub
07.26.16 | By Sanofi Le Hub
07.21.16 | By Sanofi Le Hub
07.01.16 | From BIOtechNOW
06.27.16 | By Sanofi Le Hub
06.21.16 | By Sanofi Le Hub
06.15.16 | By Sanofi Le Hub